Semaglutide unexpectedly resolved severe refractory menstrual pain without weight change in a case report | Research

The takeaway

A patient with refractory dysmenorrhea unresponsive to NSAIDs and hormonal therapy experienced significant symptom resolution on semaglutide without weight loss, suggesting anti-estrogenic and anti-inflammatory mechanisms.

Refractory menstrual pain resolved
Semaglutide resolved severe dysmenorrhea unresponsive to NSAIDs and hormones, without weight change—the first report of this unexpected GLP-1 benefit

What the researchers found

Severe refractory dysmenorrhea → resolved with semaglutide. No weight change. Transient appetite loss only. No new medications added. No lifestyle changes. Proposed mechanisms: anti-estrogenic + anti-inflammatory. First case report.

Why it matters

Dysmenorrhea affects millions of women with limited options when NSAIDs and hormones fail. A GLP-1 drug providing relief through non-weight-dependent mechanisms could expand treatment options for refractory menstrual pain.

How the study worked

Single case report.

What this study cannot tell us

Single case. Cannot prove causation. Placebo effect possible. Mechanism hypothesized not proven.

How to read the evidence

Single case report—lowest evidence but first report of this application.

When this study was published

Published in 2025.

The bigger picture

GLP-1 drugs continue to reveal benefits in unexpected conditions. Dysmenorrhea relief through anti-inflammatory mechanisms adds reproductive health to the growing list of GLP-1 therapeutic applications.

Questions still open

Would a controlled trial confirm GLP-1 efficacy for dysmenorrhea?
Is the mechanism anti-estrogenic, anti-inflammatory, or both?
Could GLP-1 drugs help with other menstrual disorders?

Common questions

Can semaglutide help with menstrual pain?

This case report describes a woman whose severe menstrual pain—unresponsive to traditional treatments—resolved after starting semaglutide. She did not lose weight, suggesting the benefit came from the drug's anti-inflammatory properties rather than weight loss. This is a single case and needs larger studies to confirm.

Why would a diabetes drug help with period pain?

GLP-1 drugs have powerful anti-inflammatory effects that go beyond blood sugar control. The authors suggest semaglutide may have reduced the uterine inflammation that drives menstrual pain, and may also have anti-estrogenic effects that reduce excessive prostaglandin production.

Read the original research

Refractory Dysmenorrhea Managed With a Glucagon-Like Peptide-1 Agonist: A Case Report.

Cureus, 17(1), e77387

View on PubMed ↗Publisher’s paper ↗

Citation

Tran, Mary; Swartz, Nicholas; Elisèe, Sabine D. (2025). Refractory Dysmenorrhea Managed With a Glucagon-Like Peptide-1 Agonist: A Case Report.. Cureus, 17(1), e77387. https://doi.org/10.7759/cureus.77387